Entire 2026 high-bandwidth memory (HBM) supply is sold out under fixed-price contracts, providing revenue visibility amid surging artificial intelligence (AI) demand. Upcoming fiscal Q3 2026 earnings release expected to offer updated guidance on Q4 revenue, gross margins, and HBM4 ramp progress for NVIDIA’s Vera Rubin platform.

Net sales fell to $326.0 million from $359.7 million in the prior-year period. The company reported a net loss of $159.7 million, or $1.73 per diluted share, compared with net income of $36.7 million, or $0.36 per diluted share, last year.

BlackBerry reported fiscal Q1 2027 revenue of approximately $153 million, up 26% year-over-year. Adjusted EBITDA grew 144% year-over-year, reflecting improved operational efficiency.

Reported adjusted EPS of $1.73, beating consensus estimates of approximately $1.70–$1.71. Net sales rose 22.9% year-over-year to $2.48 billion, driven by strong demand and acquisitions.

Net sales reached $1.198 billion for the quarter ended May 31, 2026, marking a 1.6% increase year over year. Adjusted diluted earnings per share came in at $5.31, exceeding analyst estimates of approximately $5.12.

Net sales rose 16.7% year-over-year to reflect strong contribution from the McCormick de Mexico acquisition, with organic sales growth of 1.7%. Adjusted earnings per share reached $0.80, beating consensus estimates and rising 15.9% from $0.69 in the prior-year quarter.

Darden reported fiscal 2026 fourth-quarter total sales of $3.72 billion, up 13.7% year-over-year, including a 53rd week. Adjusted diluted earnings per share from continuing operations reached $3.66, exceeding analyst expectations.

ALOY fell -17.28% during regular trading on June 25, dropping to $13.79 from the prior session's close of $16.67. The selloff was triggered by an after-hours announcement on June 24 of a $100 million private placement of common stock to institutional investors.

MAAS dropped -13.46% during regular market hours on June 24, falling to $18.38 from a previous close of $21.24, as the stock reversed sharply from its parabolic rally. The primary catalyst was a severe post-earnings reality check: the company's June 23 interim financial filing revealed a staggering -$64.61 EPS on just $0.22 million in revenue, exposing a deep disconnect between the stock's valuation and its fundamentals.

ENHA shares fell -14.10% during regular trading on June 25, dropping to $3.015 from a previous close of $3.51, extending a multi-day selloff. The decline follows the June 18 closing of the initial tranche of a $50 million PIPE financing priced at $3.89 per share, with the stock now trading significantly below that level.

AQST closed the June 25 regular session sharply lower and continued sliding in after-hours to $4.21, marking a -15.63% decline from the prior session's close of $4.99. The sell-off occurred primarily during regular market hours, with after-hours trading confirming the downside pressure and no meaningful bounce.

HTT shares surged approximately 38.8% over the past 30 days, driven primarily by a modified Dutch auction tender offer to repurchase up to 39 million ADSs. The stock jumped 23.4% on May 26 alone following the tender offer announcement, which set a price range of $2.80 to $3.20 per ADS.

AMAT shares surged approximately +6.97% in premarket trading on June 25, 2026, rising from a prior close of $588.97 to roughly $630.00. The primary catalyst was Micron Technology's (MU) historic fiscal Q3 2026 earnings beat — revenue of $41.46 billion and adjusted EPS of $25.11, both far above estimates — which directly validates accelerating AI-driven capital expenditure that flows through to Applied Materials' equipment order book.

SNDK shares surged approximately +15.33% in premarket trading on June 25, 2026, rising from a prior close of $1,914.46 to roughly $2,208.00. The primary catalyst was sector sympathy momentum ignited by Micron Technology's (MU) historic fiscal Q3 2026 earnings report, which reported revenue of $41.46 billion — more than four times year-ago levels — and issued Q4 guidance of ~$50 billion, far exceeding all analyst estimates.

MU shares surged approximately +16.48% in premarket trading on June 25, 2026, rising from a prior close of $1,048.51 to roughly $1,221.28. The primary catalyst was a historic fiscal Q3 2026 earnings report in which revenue quadrupled year-over-year to $41.46 billion — more than $5 billion above analyst consensus — marking the fifth consecutive quarterly revenue record.

INVE shares plunged approximately 21% in premarket trading on June 25, 2026, falling from the prior regular-session close of $3.69 to roughly $2.92. The primary catalyst was a Q2 2026 earnings miss combined with guidance that fell short of analyst consensus, reigniting concerns about Identiv's commercial ramp and path to profitability.

SPRY shares plunged approximately 26% in premarket trading on June 25, 2026, falling from the prior session's close of $10.54 to roughly $7.80. The primary catalyst was a late Wednesday commercial update confirming no new commercial formulary additions for neffy (epinephrine nasal spray) in the July 1, 2026 payer coverage cycle — a significant miss against market expectations.

FUL shares declined approximately 6.38% in premarket trading on June 25, 2026, falling to around $60.45 from the prior session's close of $62.75. The primary catalyst was H.B. Fuller's formal confirmation of a £715 million (~$942M) all-cash acquisition of Advanced Medical Solutions Group (AMS), a UK-based medical wound-care company.

Daktronics reported record full-year net sales of $838.7 million, up 10.9% from fiscal 2025. Fourth-quarter net sales reached $208.6 million, a 20.9% increase year-over-year.

Net revenue reached $950 million, up 5.8% year-over-year with organic revenue rising 2.6%. Reported diluted EPS of $1.23 and adjusted diluted EPS of $1.41, a 19% increase from the prior year.